The Nordic Exchange welcomes CellaVision to First North

Trading in CellaVision shares will commence today on First North in Sweden. Including CellaVision, First North now comprises 95 companies.

CellaVision AB develops and markets products for the health care sector, enabling blood cell analysis and quality assurance of morphology diagnosis.

“We warmly welcome CellaVision to First North. CellaVision is the eighteenth company to join First North this year and the company is a valuable contribution to our Health Care sector”, says Jenny Rosberg, President of Company Services at OMX.

Remium AB is Certified Adviser for CellaVision. A round lot of shares in CellaVision, whose short name is CEVI, amounts to 500 and the company is included in the Health Care sector.